Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2026, specifically reporting on a Special General Meeting of Shareholders held on August 6, 2026. The meeting was initially adjourned due to a lack of quorum but was successfully reconvened at 6:30 p.m. Israel time.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance proceedings and does not contain financial statements or operational metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary event is the successful approval of the agenda item described in the Proxy Statement filed on July 2, 2026, following the initial failure to achieve a quorum.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose new risks, contingencies, or unusual items beyond the procedural delay in convening the shareholder meeting.
Investor Verification Checklist
- Verify the specific agenda item approved by shareholders by reviewing the Proxy Statement filed on July 2, 2026 (Exhibit 99.2).
- Confirm the final voting results and the number of shares represented at the adjourned meeting.
- Check subsequent filings for any financial updates or operational milestones related to the approved agenda item.